Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
<p>Multivariable Cox proportional hazards models for time to progression and time to death</p>
Salvato in:
| Autore principale: | |
|---|---|
| Altri autori: | , , , , , , , , , , , , , , |
| Pubblicazione: |
2025
|
| Soggetti: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1849927632305520640 |
|---|---|
| author | Sofie H. Tolmeijer (15313251) |
| author2 | Emmy Boerrigter (15313254) Takayuki Sumiyoshi (15034119) Edmond M. Kwan (15313257) Sarah W.S. Ng (14960841) Matti Annala (15313260) Gráinne Donnellan (15313263) Cameron Herberts (14960820) Guillemette E. Benoist (15313266) Paul Hamberg (15313269) Diederik M. Somford (15035198) Inge M. van Oort (15035171) Jack A. Schalken (15313272) Niven Mehra (15011036) Nielka P. van Erp (15313275) Alexander W. Wyatt (14960922) |
| author2_role | author author author author author author author author author author author author author author author |
| author_facet | Sofie H. Tolmeijer (15313251) Emmy Boerrigter (15313254) Takayuki Sumiyoshi (15034119) Edmond M. Kwan (15313257) Sarah W.S. Ng (14960841) Matti Annala (15313260) Gráinne Donnellan (15313263) Cameron Herberts (14960820) Guillemette E. Benoist (15313266) Paul Hamberg (15313269) Diederik M. Somford (15035198) Inge M. van Oort (15035171) Jack A. Schalken (15313272) Niven Mehra (15011036) Nielka P. van Erp (15313275) Alexander W. Wyatt (14960922) |
| author_role | author |
| dc.creator.none.fl_str_mv | Sofie H. Tolmeijer (15313251) Emmy Boerrigter (15313254) Takayuki Sumiyoshi (15034119) Edmond M. Kwan (15313257) Sarah W.S. Ng (14960841) Matti Annala (15313260) Gráinne Donnellan (15313263) Cameron Herberts (14960820) Guillemette E. Benoist (15313266) Paul Hamberg (15313269) Diederik M. Somford (15035198) Inge M. van Oort (15035171) Jack A. Schalken (15313272) Niven Mehra (15011036) Nielka P. van Erp (15313275) Alexander W. Wyatt (14960922) |
| dc.date.none.fl_str_mv | 2025-11-25T13:28:35Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30709275 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Early_On-treatment_Changes_in_Circulating_Tumor_DNA_Fraction_and_Response_to_Enzalutamide_or_Abiraterone_in_Metastatic_Castration-Resistant_Prostate_Cancer/30709275 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy |
| dc.title.none.fl_str_mv | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Multivariable Cox proportional hazards models for time to progression and time to death</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_e5c9b2437860079ab11a05f282205a16 |
| identifier_str_mv | 10.1158/1078-0432.30709275 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30709275 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate CancerSofie H. Tolmeijer (15313251)Emmy Boerrigter (15313254)Takayuki Sumiyoshi (15034119)Edmond M. Kwan (15313257)Sarah W.S. Ng (14960841)Matti Annala (15313260)Gráinne Donnellan (15313263)Cameron Herberts (14960820)Guillemette E. Benoist (15313266)Paul Hamberg (15313269)Diederik M. Somford (15035198)Inge M. van Oort (15035171)Jack A. Schalken (15313272)Niven Mehra (15011036)Nielka P. van Erp (15313275)Alexander W. Wyatt (14960922)CancerCancer Detection and DiagnosisMethods and TechnologyBiomarkersCirculating tumor cells/DNA/exosomesGenitourinary CancersProstate cancerLiquid Biopsy<p>Multivariable Cox proportional hazards models for time to progression and time to death</p>2025-11-25T13:28:35ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709275https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Early_On-treatment_Changes_in_Circulating_Tumor_DNA_Fraction_and_Response_to_Enzalutamide_or_Abiraterone_in_Metastatic_Castration-Resistant_Prostate_Cancer/30709275CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307092752025-11-25T13:28:35Z |
| spellingShingle | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer Sofie H. Tolmeijer (15313251) Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy |
| status_str | publishedVersion |
| title | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_full | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_fullStr | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_full_unstemmed | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_short | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| title_sort | Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer |
| topic | Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy |